Inovio Pharma (INO) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $0.77 +4.05%
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
WPRT, ITRG, ALM, More
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
WPRT, ITRG, ALM, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $390 thousand versus the consensus estimate of $116.67 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
- Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
